Decreased Monocyte HLA-DR Expression in Patients with Sepsis and Acute Kidney Injury
暂无分享,去创建一个
Chung-Chieh Yu | Huang-Pin Wu | D. Chuang | K. Kao | Shih-Wei Lin | Pi-Hua Liu | L. Chuang | Li-Fu Li | C. Chu
[1] S. Kaneko,et al. Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury , 2021, Biology open.
[2] A. Mebazaa,et al. Role of Damage-Associated Molecular Patterns in Septic Acute Kidney Injury, From Injury to Recovery , 2021, Frontiers in Immunology.
[3] D. Nakano. Septic acute kidney injury: a review of basic research , 2020, Clinical and Experimental Nephrology.
[4] T. Rimmele,et al. Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes , 2020, Critical Care.
[5] T. Evans,et al. Plasma S100A8/A9 heterodimer is an early prognostic marker of acute kidney injury associated with cardiac surgery. , 2019, Biomarkers in medicine.
[6] Zhongqing Chen,et al. SIRT1-mediated HMGB1 deacetylation suppresses sepsis-associated acute kidney injury. , 2019, American journal of physiology. Renal physiology.
[7] K. Prasad. Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases? , 2018, Molecular and Cellular Biochemistry.
[8] Yin-ku Lin,et al. Effect of Eucommia ulmoides Oliv., Gynostemma pentaphyllum (Thunb.) Makino, and Curcuma longa L. on Th1- and Th2-cytokine responses and human leukocyte antigen-DR expression in peripheral blood mononuclear cells of septic patients. , 2018, Journal of ethnopharmacology.
[9] D. Tousoulis,et al. The Role of Oxidative Stress , 2018 .
[10] Hu Peng,et al. Dynamic monitoring of monocyte HLA-DR expression for the diagnosis, prognosis, and prediction of sepsis. , 2017, Frontiers in bioscience.
[11] Alan E. Jones,et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.
[12] R. Bellomo,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[13] A. Zarbock,et al. Acute kidney injury: definition, diagnosis and epidemiology. , 2016, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.
[14] S. Yamagishi,et al. Receptor for advanced glycation endproducts and progressive kidney disease , 2015, Current opinion in nephrology and hypertension.
[15] A. Fabio,et al. Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsis , 2013, Scandinavian journal of clinical and laboratory investigation.
[16] A. Khwaja. KDIGO Clinical Practice Guidelines for Acute Kidney Injury , 2012, Nephron Clinical Practice.
[17] Yu-Chen Hou,et al. Glutamine administration ameliorates sepsis-induced kidney injury by downregulating the high-mobility group box protein-1-mediated pathway in mice. , 2012, AJP - Renal Physiology.
[18] Huang-Pin Wu,et al. Serial increase of IL-12 response and human leukocyte antigen-DR expression in severe sepsis survivors , 2011, Critical care.
[19] A. Lin,et al. Changes of monocyte human leukocyte antigen-DR expression as a reliable predictor of mortality in severe sepsis , 2011, Critical care.
[20] R. Pirracchio,et al. Monocytic HLA‐DR expression in intensive care patients: Interest for prognosis and secondary infection prediction * , 2009, Critical care medicine.
[21] C. Heizmann,et al. Binding of S100 proteins to RAGE: an update. , 2009, Biochimica et biophysica acta.
[22] C. Ronco,et al. Oxidative Stress and ‘Monocyte Reprogramming’ in Septic Patients with Acute Kidney Injury Requiring CRRT , 2008, Blood Purification.
[23] Joseph V Bonventre,et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. , 2005, Journal of the American Society of Nephrology : JASN.
[24] V. Pettilä,et al. Predictive value of interleukins 6, 8 and 10, and low HLA-DR expression in acute renal failure. , 2004, Clinical nephrology.
[25] D M Linton,et al. Severity of disease classification system. , 1991, Critical care medicine.
[26] E. Draper,et al. APACHE II: A severity of disease classification system , 1985, Critical care medicine.
[27] W. Knaus,et al. APACHE II: a severity of disease classification system. , 1985 .